Uncategorized
InnFocus completes $32.8 million financing for MicroShunt system
InnFocus completed a $32.8 million Series C financing to fund the study of its MicroShunt glaucoma drainage system, according to a press release.The financing, which includes investors Hoya Corporation, Saints Capital Everest, Santen Pharmaceutical and Crown Venture Fund, will fund the system’s final phase of clinical trials.